Centre Hospitalier Yves Le Foll
- Address
- 10 Rue Marcel Proust, 22000 Saint-Brieuc, France
Centre Hospitalier Yves Le Foll - Multi-Specialty Research Center
Centre Hospitalier Yves Le Foll is a comprehensive clinical research facility engaged in diverse therapeutic areas spanning hematologic malignancies, cardiovascular diseases, autoimmune disorders, and oncology. The center demonstrates particular expertise in conducting Phase 3 trials evaluating innovative treatment strategies and comparing novel therapeutic combinations against standard care protocols.
- Hematologic malignancies including multiple myeloma, follicular lymphoma, and marginal zone lymphoma with focus on minimal residual disease-adapted strategies
- Cardiovascular research encompassing acute myocardial infarction management and acute myocarditis treatment approaches
- Renal and autoimmune disorders, particularly ANCA vasculitis in end-stage renal disease populations
- Gastrointestinal oncology specializing in high-risk stage III colon cancer adjuvant therapy
The research portfolio reflects a strong commitment to precision medicine approaches, including minimal residual disease monitoring in multiple myeloma and cardiac magnetic resonance imaging guided therapy in myocarditis. The center's trials evaluate cutting-edge immunotherapies such as daratumumab and tafasitamab, as well as targeted agents like evolocumab for lipid management post-myocardial infarction, demonstrating capability in complex multi-arm randomized controlled trials aimed at optimizing patient outcomes across multiple disease states.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 31 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Yves Le Foll
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTE | Centre Hospitalier Universitaire De Saint Etienne | Phase III | Recruiting | Aug 2023 | — |
IMP list
lock Showing 1 of 31 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Lenalidomide | 3 | Unknown | 2019-10-07 | 2021-06-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.